Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal

Roeland Huijgen, Iris Kindt, Sjoerd B. J. Verhoeven et al. · 2010

Read Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal by Roeland Huijgen, Iris Kindt, Sjoerd B. J. Verhoeven et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009220.txt.

Description

Roeland Huijgen and colleagues published this heart risk study in PLOS ONE in 2010. It follows people with familial hypercholesterolemia, an inherited cause of very high cholesterol. Without treatment, their risk of early heart disease is high. Cholesterol-lowering drugs cut that risk sharply, and guidelines set ambitious targets for their blood levels.

The team checked patients two years after a DNA test confirmed their diagnosis. Most patients were on cholesterol-lowering treatment by then. Even so, only a minority had reached the treatment goal for LDL cholesterol. The gap between being treated and being treated enough is the study's warning for clinics.

Catalog record

CREATORRoeland Huijgen, Iris Kindt, Sjoerd B. J. Verhoeven et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009220

Browse the full library · About the Tower of Babel